27 Juin, 2024 - 27 Juin, 2024
The transformative potential of “EEG as Biomarkers for Psychiatric Treatment” holds significant promise in revolutionizing psychiatric care. Currently, psychiatric diagnoses and treatments are predominantly based on subjective assessments, which can lead to inconsistencies and misdiagnoses. The implementation of EEG biomarkers aims to provide objective, quantifiable data to guide more precise and personalized psychiatric interventions. EEG biomarkers offer a promising avenue for improving the accuracy of psychiatric diagnoses and tailoring treatments to individual patients' needs. By leveraging EEG data, clinicians can move beyond traditional methods, incorporating scientific rigor and precision into their practice. This shift could lead to more consistent and effective treatment outcomes, ultimately enhancing patient care. The exploration of this topic is critical as psychiatric methodologies have evolved significantly over the years. By understanding and integrating EEG biomarkers, the field of psychiatry can take a significant step forward in delivering better, more reliable care for patients with psychiatric conditions.